BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16967504)

  • 1. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra.
    Nosheny RL; Bachis A; Aden SA; De Bernardi MA; Mocchetti I
    J Neurobiol; 2006 Oct; 66(12):1311-21. PubMed ID: 16967504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C; Kirik D; Björklund A
    Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats.
    Lu X; Hagg T
    J Comp Neurol; 1997 Nov; 388(3):484-94. PubMed ID: 9368855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
    Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of donor age and brain-derived neurotrophic factor on the survival of dopaminergic neurons and axonal growth in postnatal rat nigrostriatal cocultures.
    Ostergaard K; Jones SA; Hyman C; Zimmer J
    Exp Neurol; 1996 Dec; 142(2):340-50. PubMed ID: 8934565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minor immunoreactivity in GDNF-, BDNF-, or NT-3-treated substantia nigra allografts.
    Shinoda M; Hoffer BJ; Olson L
    J Neural Transplant Plast; 1997; 6(2):83-96. PubMed ID: 9306240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrastriatal infusions of brain-derived neurotrophic factor: retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat.
    Mufson EJ; Kroin JS; Sobreviela T; Burke MA; Kordower JH; Penn RD; Miller JA
    Exp Neurol; 1994 Sep; 129(1):15-26. PubMed ID: 7523178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
    Connor B; Kozlowski DA; Schallert T; Tillerson JL; Davidson BL; Bohn MC
    Gene Ther; 1999 Dec; 6(12):1936-51. PubMed ID: 10637445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration.
    Natsume A; Mata M; Goss J; Huang S; Wolfe D; Oligino T; Glorioso J; Fink DJ
    Exp Neurol; 2001 Jun; 169(2):231-8. PubMed ID: 11358438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injury induced c-Jun expression and phosphorylation in the dopaminergic nigral neurons of the rat: correlation with neuronal death and modulation by glial-cell-line-derived neurotrophic factor.
    Vaudano E; Rosenblad C; Björklund A
    Eur J Neurosci; 2001 Jan; 13(1):1-14. PubMed ID: 11134999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain.
    Beck KD; Valverde J; Alexi T; Poulsen K; Moffat B; Vandlen RA; Rosenthal A; Hefti F
    Nature; 1995 Jan; 373(6512):339-41. PubMed ID: 7830767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of GDNF in neuronal protection against 6-OHDA-induced parkinsonism following intracerebral transplantation of fetal kidney tissues in adult rats.
    Borlongan CV; Zhou FC; Hayashi T; Su TP; Hoffer BJ; Wang Y
    Neurobiol Dis; 2001 Aug; 8(4):636-46. PubMed ID: 11493028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked dopaminergic cell loss subsequent to developmental, intranigral expression of glial cell line-derived neurotrophic factor.
    Chun HS; Yoo MS; DeGiorgio LA; Volpe BT; Peng D; Baker H; Peng C; Son JH
    Exp Neurol; 2002 Feb; 173(2):235-44. PubMed ID: 11822887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single intramesencephalic injection of brain-derived neurotrophic factor induces persistent rotational asymmetry in rats.
    Shults CW; Matthews RT; Altar CA; Hill LR; Langlais PJ
    Exp Neurol; 1994 Feb; 125(2):183-94. PubMed ID: 8313937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of GDNF on nigrostriatal dopaminergic function in response to a two-pulse K(+) stimulation.
    Xu K; Dluzen DE
    Exp Neurol; 2000 Dec; 166(2):450-7. PubMed ID: 11085910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lesion-induced increase of BDNF is greater in the striatum of young versus old rat brain.
    Yurek DM; Fletcher-Turner A
    Exp Neurol; 2000 Jan; 161(1):392-6. PubMed ID: 10683304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra.
    Howells DW; Porritt MJ; Wong JY; Batchelor PE; Kalnins R; Hughes AJ; Donnan GA
    Exp Neurol; 2000 Nov; 166(1):127-35. PubMed ID: 11031089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult.
    Tomac A; Widenfalk J; Lin LF; Kohno T; Ebendal T; Hoffer BJ; Olson L
    Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8274-8. PubMed ID: 7667281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the pattern of brain-derived neurotrophic factor immunoreactivity in the rat brain after acute and subchronic haloperidol treatment.
    Dawson NM; Hamid EH; Egan MF; Meredith GE
    Synapse; 2001 Jan; 39(1):70-81. PubMed ID: 11071712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.